By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


bluebird bio 

840 Memorial Drive

Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-491-5601 Fax: 617-576-2421


Key Statistics

Ownership: Public

Web Site: bluebird bio
Symbol: BLUE


Gene Therapy

Company News
bluebird bio (BLUE) Announces Management Appointments 12/2/2016 10:34:20 AM
bluebird bio (BLUE), Celgene (CELG)'s Multiple Myeloma CAR-T Drug Shines in Tiny Study 12/1/2016 5:38:30 AM
bluebird bio (BLUE) Reports Third Quarter 2016 Financial Results And Recent Operational Progress 11/3/2016 11:50:40 AM
Why Biogen (BIIB), bluebird bio (BLUE) and Xencor are 3 Stocks to Look at in November 11/3/2016 6:28:25 AM
If You Had to Choose, bluebird bio (BLUE) vs. Inovio Pharma (INO) 10/14/2016 6:45:50 AM
bluebird bio (BLUE) Provides Update On Lentiglobin Programs And Research And Development Strategy At Gene Therapy Day 10/13/2016 11:44:00 AM
bluebird bio (BLUE) Announces Topics For Gene Therapy Day, October Investor Presentation 10/6/2016 10:18:42 AM
MediGene AG (MDGEF.PK), bluebird bio (BLUE) Partner Up in $1 Billion+ Cancer Immunotherapy Deal 9/29/2016 6:15:23 AM
bluebird bio (BLUE) Release: Lentiglobin Investigational Gene Therapy For Transfusion-Dependent Beta-Thalassemia Accepted Into EMA’s PRIME Program 9/21/2016 11:37:31 AM
bluebird bio (BLUE) Announces Webcast Of Gene Therapy Day 9/9/2016 11:14:51 AM